MedPath
NMPA Approval

Latanoprost Eye Drops

国药准字H20153305

December 11, 2020

国药准字H20153305

Drug Information

拉坦前列素滴眼液

眼用制剂(滴眼剂)

2.5ml : 0.125mg

化学药品

December 11, 2020

Company Information

Applicant Company

湖北省武汉市经济技术开发区高新技术工业园28号

Manufacturing Company

湖北省武汉市经济技术开发区高新技术工业园28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉坦前列素滴眼液 - NMPA 批准文号 | MedPath